Article
CRISPR/Cas9 and cancer targets: future possibilities and present challenges.
Oncotarget - 15 Mar 2016
White Martyn K, Khalili Kamel
Abstract excerpt
All cancers have multiple mutations that can largely be grouped into certain classes depending on the function of the gene in which they lie and these include oncogenic changes that enhance cellular proliferation, loss of function of tumor suppressors that regulate cell growth potential and induction of metabolic enzymes that confer resistance to chemotherapeutic agents. Thus the ability to correct such mutations...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
